Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-120,000
Closed -$3K 338
2024
Q4
$3K Buy
+120,000
New +$663K ﹤0.01% 410
2024
Q1
Sell
-150,000
Closed -$37.5K 521
2023
Q4
$37.5K Hold
150,000
﹤0.01% 430
2023
Q3
$46.3K Buy
+150,000
New +$585K ﹤0.01% 493

Other funds holding ARDX

UBS O'Connor's ARDX Position: Q1 2025 in Review

UBS O'Connor sold out of Ardelyx (ARDX) in Q1 2025, closing a stake of 49,701 shares — an estimated $252K sold.

UBS O'Connor first reported a position in ARDX in Q2 2018 and held it in 9 quarters. The position peaked at $2.22M in Q2 2018. 221 funds tracked by Wall St. Rank hold ARDX as of Q1 2025.

  • UBS O'Connor reported no remaining Ardelyx position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 49,701 Ardelyx shares in Q1 2025, an estimated $252K.
  • UBS O'Connor first reported a position in Ardelyx in Q2 2018 and held it in 9 quarters.
  • UBS O'Connor's Ardelyx position peaked at $2.22M in Q2 2018.
  • 221 funds tracked by Wall St. Rank held Ardelyx as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.